•
Mar 31, 2024

Reneo Pharmaceuticals Q1 2024 Earnings Report

Total Revenue
$0
EPS
-$0.25
Previous year: -$0.6
-58.3%
Gross Profit
-$16K
Cash and Equivalents
$82.8M
Previous year: $30.4M
+172.5%
Free Cash Flow
-$21M
Previous year: -$9.22M
+127.9%
Total Assets
$84.6M
Previous year: $98.9M
-14.4%

Reneo Pharmaceuticals

Reneo Pharmaceuticals